Brain age gap may be a potential biomarker for cognitive impairment, revealing that adults with sickle cell anemia and those from economically deprived backgrounds show signs of premature brain aging linked...
A study investigated the neural mechanisms behind aggressive behaviors in patients with Alzheimer disease and amnestic mild cognitive impairment, revealing distinct associations between brain activity and...
A study on mild cognitive impairment found that depression and agitation are linked to regional brain atrophy and faster cognitive decline, suggesting these symptoms may indicate a higher risk for...
Researchers evaluated the association between neuropsychiatric symptoms, such as agitation and apathy, in patients with Alzheimer disease and the rate of functional decline.
Researchers used data from the Alzheimer's Disease Neuroimaging Initiative database to identify specific brain regions associated with hyperactive neuropsychiatric symptoms among patients with mild...
In this COVID-19 roundup, researchers report on an increase in outpatient care following COVID-19 infection, cognition and memory impairment among those recovering from COVID-19, and more.
The FDA has examined the results of a recent confirmatory trial to verify the clinical benefit of an amyloid beta-directed antibody for the treatment of Alzheimer disease.
To better understand the relationship between nutritional status and cognitive decline, the researchers examined the impact of vitamin D levels on the risk of Alzheimer disease and dementia in older adults....
In this COVID-19 roundup, we discuss the FDA approval of an additional COVID-19 booster dose in certain populations, the latest FDA update on emergency use of sotrovimab, and cognitive impairment...
